Investors are keeping a close eye on gastroenterology, according to McDermott Health's "2023 Physician Practice Management" report.
According to the report, gastroenterology has high utilization of evaluation and management codes, which increased for 2021. Medicare ASC payments for colonoscopies with lesion removals and colonoscopies and biopsies are expected to increase in 2023, according to VMG Health's "ASCs in 2022: A Year in Review" report. These factors put gastroenterology in a great spot for growth.
Gastroenterology is the most-represented specialty among ASCs, making up 32 percent of all cases, according to VMG Health's "Multi-Specialty ASC Benchmarking Study" for 2022.
Its current popularity combined with its potential for growth make it a hot commodity for investors.